Gasbarrini, Antonio

What is the Healthy Gut Microbiota Composition? A Changing Ecosystem across Age, Environment, Diet, and Diseases

Rinninella, E., Raoul, P., Cintoni, M., Franceschi, F., Miggiano, G. A. D., Gasbarrini, A., & Mele, M. C. (2019) · Microorganisms

Gut microbiota and healthProbiotics and Fermented Foods

Cited by 3,462

Commensal clostridia: Leading players in the maintenance of gut homeostasis

Lopetuso, L. R., Scaldaferri, F., Petito, V., & Gasbarrini, A. (2013) · Gut Pathogens

Gut microbiota and healthClostridium difficile and Clostridium perfringens research

Cited by 753

Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study

Qin, S., Chan, S. L., Gu, S., Bai, Y., Ren, Z., Lin, X., Chen, Z., Jia, W., Jin, Y., Guo, Y., et al. (2023) · The Lancet

Hepatocellular Carcinoma Treatment and PrognosisCancer Immunotherapy and Biomarkers

Cited by 746

Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection

Cammarota, G., Masucci, L., Ianiro, G., Bibbò, S., Dinoi, G., Costamagna, G., Sanguinetti, M., & Gasbarrini, A. (2015) · Alimentary Pharmacology & Therapeutics

Clostridium difficile and Clostridium perfringens researchGut microbiota and health

Cited by 558

International consensus conference on stool banking for faecal microbiota transplantation in clinical practice

Cammarota, G., Ianiro, G., Kelly, C. R., Mullish, B. H., Allegretti, J. R., Kassam, Z., Putignani, L., Fischer, M., Keller, J. J., Costello, S. P., et al. (2019) · Gut

Clostridium difficile and Clostridium perfringens researchGut microbiota and health

Cited by 506

Treatment of Relapsing Mild-to-Moderate Ulcerative Colitis With the Probiotic VSL#3 as Adjunctive to a Standard Pharmaceutical Treatment: A Double-Blind, Randomized, Placebo-Controlled Study

Tursi, A., Brandimarte, G., Papa, A., Giglio, A., Elisei, W., Giorgetti, G. M., Forti, G., Morini, S., Hassan, C., Pistoia, M. A., et al. (2010) · American Journal of Gastroenterology

Inflammatory Bowel DiseaseProbiotics and Fermented Foods

Cited by 489

Fecal Microbiota Transplantation for the Treatment of Clostridium difficile Infection: A Systematic Review

Cammarota, G., Ianiro, G., & Gasbarrini, A. (2014) · Journal of Clinical Gastroenterology

Clostridium difficile and Clostridium perfringens researchGut microbiota and health

Cited by 428

Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases

Ianiro, G., Punčochář, M., Karcher, N., Porcari, S., Armanini, F., Asnicar, F., Beghini, F., Blanco-Míguez, A., Cumbo, F., Manghi, P., et al. (2022) · Nature Medicine

Gut microbiota and healthClostridium difficile and Clostridium perfringens research

Cited by 366

Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma

Sangro, B., Chan, S. L., Kelley, R. K., Lau, G., Kudo, M., Sukeepaisarnjaroen, W., Yarchoan, M., De Toni, E. N., Furuse, J., Kang, Y. K., et al. (2024) · Annals of Oncology

Hepatocellular Carcinoma Treatment and PrognosisCancer Immunotherapy and Biomarkers

Cited by 365

The role of small intestinal bacterial overgrowth in Parkinson's disease

Fasano, A., Bove, F., Gabrielli, M., Petracca, M., Zocco, M. A., Ragazzoni, E., Barbaro, F., Piano, C., Fortuna, S., Tortora, A., et al. (2013) · Movement Disorders

Parkinson's Disease Mechanisms and TreatmentsGastrointestinal motility and disorders

Cited by 344

Key determinants of success in fecal microbiota transplantation: From microbiome to clinic

Porcari, S., Benech, N., Valles-Colomer, M., Segata, N., Gasbarrini, A., Cammarota, G., Sokol, H., & Ianiro, G. (2023) · Cell Host & Microbe

Clostridium difficile and Clostridium perfringens researchGut microbiota and health

Cited by 331

Gut microbiome, big data and machine learning to promote precision medicine for cancer

Cammarota, G., Ianiro, G., Ahern, A., Carbone, C., Temko, A., Claesson, M. J., Gasbarrini, A., & Tortora, G. (2020) · Nature Reviews Gastroenterology & Hepatology

Gut microbiota and healthColorectal Cancer Treatments and Studies

Cited by 324

Autism, Gastrointestinal Symptoms and Modulation of Gut Microbiota by Nutritional Interventions

Ristori, M. V., Quagliariello, A., Reddel, S., Ianiro, G., Vicari, S., Gasbarrini, A., & Putignani, L. (2019) · Nutrients

Gut microbiota and healthAutism Spectrum Disorder Research

Cited by 214

Efficacy of different faecal microbiota transplantation protocols for Clostridium difficile infection: A systematic review and meta‐analysis

Ianiro, G., Maida, M., Burisch, J., Simonelli, C., Hold, G., Ventimiglia, M., Gasbarrini, A., & Cammarota, G. (2018) · United European Gastroenterology Journal

Clostridium difficile and Clostridium perfringens researchGut microbiota and health

Cited by 203

Systematic review with meta‐analysis: efficacy of faecal microbiota transplantation for the treatment of irritable bowel syndrome

Ianiro, G., Eusebi, L. H., Black, C. J., Gasbarrini, A., Cammarota, G., & Ford, A. C. (2019) · Alimentary Pharmacology & Therapeutics

Gastrointestinal motility and disordersGut microbiota and health

Cited by 188

Prevalence of small intestinal bacterial overgrowth in Parkinson’s disease

Gabrielli, M., Bonazzi, P., Scarpellini, E., Bendia, E., Lauritano, E. C., Fasano, A., Ceravolo, M. G., Capecci, M., Rita Bentivoglio, A., Provinciali, L., et al. (2011) · Movement Disorders

Parkinson's Disease Mechanisms and TreatmentsGastrointestinal motility and disorders

Cited by 175

Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score

Carbone, M., Nardi, A., Flack, S., Carpino, G., Varvaropoulou, N., Gavrila, C., Spicer, A., Badrock, J., Bernuzzi, F., Cardinale, V., et al. (2018) · The Lancet Gastroenterology & Hepatology

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 155

Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection—single versus multiple infusions

Ianiro, G., Masucci, L., Quaranta, G., Simonelli, C., Lopetuso, L. R., Sanguinetti, M., Gasbarrini, A., & Cammarota, G. (2018) · Alimentary Pharmacology & Therapeutics

Clostridium difficile and Clostridium perfringens researchGut microbiota and health

Cited by 152

Reorganisation of Faecal Microbiota Transplant Services During the COVID-19 Pandemic

Ianiro, G., Mullish, B. H., Kelly, C. R., Kassam, Z., Kuijper, E. J., Ng, S. C., Iqbal, T. H., Allegretti, J. R., Bibbò, S., Sokol, H., et al. (2020) · Gut

Clostridium difficile and Clostridium perfringens researchGut microbiota and health

Cited by 147

Recent Insights on the Maternal Microbiota: Impact on Pregnancy Outcomes

Di Simone, N., Santamaria Ortiz, A., Specchia, M., Tersigni, C., Villa, P., Gasbarrini, A., Scambia, G., & D’Ippolito, S. (2020) · Frontiers in Immunology

Gut microbiota and healthReproductive tract infections research

Cited by 146

The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease

Lopetuso, L. R., Deleu, S., Godny, L., Petito, V., Puca, P., Facciotti, F., Sokol, H., Ianiro, G., Masucci, L., Abreu, M., et al. (2023) · Gut

Inflammatory Bowel DiseaseGut microbiota and health

Cited by 129

The effect of Lactobacillus reuteri supplementation in adults with chronic functional constipation: a randomized, double-blind, placebo-controlled trial.

Ojetti, V., Ianiro, G., Tortora, A., D‘Angelo, G., Di Rienzo, T. A., Bibbò, S., Migneco, A., & Gasbarrini, A. (2014) · Journal of Gastrointestinal and Liver Diseases

Gastrointestinal motility and disordersProbiotics and Fermented Foods

Cited by 125

The role of methane in intestinal diseases

Roccarina, D., Lauritano, E. C., Gabrielli, M., Franceschi, F., Ojetti, V., & Gasbarrini, A. (2010) · American Journal of Gastroenterology

Gastrointestinal motility and disordersGut microbiota and health

Cited by 117

Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma

Cabibbo, G., Petta, S., Barbara, M., Attardo, S., Bucci, L., Farinati, F., Giannini, E. G., Negrini, G., Ciccarese, F., Rapaccini, G. L., et al. (2017) · Journal of Hepatology

Hepatocellular Carcinoma Treatment and PrognosisHepatitis C virus research

Cited by 110